PRGO Q3 2022 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q3 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B+5.5% YoY

Gross Profit

$363M33.0% margin

Operating Income

$33M3.0% margin

Net Income

-$49M-4.5% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

-1.9%

Cash Flow

Operating Cash Flow

$59M

Free Cash Flow

$38M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$10.7B

Total Liabilities

$6.1B

Stockholders' Equity

$4.6B

Cash & Equivalents

$469M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.0B	+5.5%
Gross Profit	$363M	$336M	+7.9%
Operating Income	$33M	$438M	-92.4%
Net Income	-$49M	-$59M	+16.1%

Revenue Segments

Consumer Self-Care Americas

$722M66%

Consumer Self-Care International

$378M34%

Geographic Segments

UNITED STATES

$716M65%

Europe

$365M33%

Other Geographical Areas

$19M2%

IRELAND

$6M1%